- Investing Ideas
- /
- Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Chilean Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
12
0 new
Companies with a Value score of at least 3, ordered by Value score
12 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | US$128.80 | 0% | 24.2% | US$250.9b | US$169.93 | PE20.7x | E15.6% | 3.1% | ||
MRKCL | CL$99,470.00 | 0% | 6.3% | CL$250.9b | CL$131,235.30 | PE20.7x | E15.6% | 3.1% | ||
GILDCL | CL$79,000.00 | 0% | n/a | CL$112.4b | CL$84,869.62 | PE892.1x | E40.7% | 3.4% | ||
BIIBCL | CL$151,967.00 | -41.8% | -41.8% | CL$23.0b | CL$242,239.54 | PE14.2x | E12.4% | n/a | ||
BIIB | US$245.00 | 0% | 0% | US$23.0b | US$390.54 | PE14.2x | E12.4% | n/a | ||
GILD | US$89.71 | 0% | 36.9% | US$112.4b | US$96.38 | PE892.1x | E40.7% | 3.4% | ||
AMGNCL | CL$305,690.00 | 0% | n/a | CL$158.3b | CL$346,717.44 | PE37.4x | E19.1% | 3.1% | ||
PFE | US$27.95 | 0% | -6.2% | US$145.4b | US$35.47 | PE34x | E16.8% | 6.5% | ||
PFECL | CL$28,095.00 | 0% | -32.5% | CL$145.4b | CL$35,650.89 | PE34x | E16.8% | 6.5% | ||
LLY | US$745.48 | -9.6% | n/a | US$673.5b | US$988.83 | PE80.5x | E29.2% | 0.7% | ||
AMGN | US$255.16 | 0% | 0% | US$158.3b | US$289.41 | PE37.4x | E19.1% | 3.1% | ||
LLYCL | CL$727,465.00 | -2.5% | n/a | CL$673.5b | CL$964,930.32 | PE80.5x | E29.2% | 0.7% |
Page 1 of 1